{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:31:36Z","timestamp":1769693496302,"version":"3.49.0"},"reference-count":19,"publisher":"Kurume Medical Journal","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kurume Med. J."],"published-print":{"date-parts":[[2019,3,31]]},"DOI":"10.2739\/kurumemedj.ms661003","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T22:05:17Z","timestamp":1588284317000},"page":"71-75","source":"Crossref","is-referenced-by-count":4,"title":["Remarkable Improvement in Clinical Course and Serum KL-6 Levels after Initiation of High-Dose Inhaled Budesonide in Pulmonary Sarcoidosis"],"prefix":"10.2739","volume":"66","author":[{"given":"YOSHITAKA","family":"MORIMATSU","sequence":"first","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine"},{"name":"Department of Environmental Medicine, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAKI","family":"OKAMOTO","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOMOTAKA","family":"KAWAYAMA","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUSUKE","family":"MIZOGUCHI","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HARUKI","family":"IMAOKA","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDEO","family":"OGINO","sequence":"additional","affiliation":[{"name":"Shun-yokai Kawazu Internal and Respiratoly Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKETOSHI","family":"KAWAZU","sequence":"additional","affiliation":[{"name":"Shun-yokai Kawazu Internal and Respiratoly Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TATSUYA","family":"ISHITAKE","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOMOAKI","family":"HOSHINO","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1445","reference":[{"key":"1","unstructured":"1. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF et al. TS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149-173."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Miyoshi S, Hamada H, Kadowaki T, Hamaguchi N, Ito R et al. Comparative evaluation of serum markers in palmonary sarcoidosis. Chest 2010; 137:1391-1397.","DOI":"10.1378\/chest.09-1975"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ohtsuki Y, Fujita J, Hachisuka Y, Uomoto M, Okada Y et al. Immunohistochemical and immunoelection microscopic studies of the localization of KL-6 and epitherlial membrane antigen (EMA) in presumably normal pulmonary tissue and in interstitial pneumonia. Med Mol Morphol 2007; 40:198-202.","DOI":"10.1007\/s00795-007-0382-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Janssen R, Sato H, Grutters JC, Bernard A, van Velzen-Blad H et al. Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis. Chest 2003; 124:2119-2125.","DOI":"10.1378\/chest.124.6.2119"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kobayashi J and Kitamura S. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 1996; 109:1276-1282.","DOI":"10.1378\/chest.109.5.1276"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Eklund A and Blaschke E. Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarciodosis. Thorax 1986; 41:629-634.","DOI":"10.1136\/thx.41.8.629"},{"key":"7","unstructured":"7. Barnes PJ. Airway pharmacology. In: Murray JF, Nadel JA, eds. Text book of respiratory medicine. Philadelphia, PA: W.B. Saunders, pp249-269."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chou SH, Chen TW, Chuang HY, Kao EL, and Huang MF. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease. J Clin Pharmacy and Theraputics 2006; 31:363-368.","DOI":"10.1111\/j.1365-2710.2006.00751.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Milman N, Graudal N, Grode G and Munch E. No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study. J Intern Med 1994; 236:285-290.","DOI":"10.1111\/j.1365-2796.1994.tb00798.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Selroos OB. Use of budesonide in the treatment of pulmonary sarcoidosis. Am NY Acad Sci 1986; 465:713-721.","DOI":"10.1111\/j.1749-6632.1986.tb18550.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Alberts C, van der Mark TW, Jansen HM, and the Dutch Study Group on Pulmonary Sarcoidosis. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Eur Respir J 1995; 5:682-688.","DOI":"10.1183\/09031936.95.08050682"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamaguchi T. Treatment of Sardoidosis: A Case-Based Approach. Jpn J Sarcoidosis and other Granulomatous disorders (in Japanese) 2014; 34:7-10.","DOI":"10.7878\/jjsogd.34.7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ohno S, Nakazawa S, Kobayashi A, Yamasawa H, Bando M et al. Inhaled corticosteroid rapidly improved pulmonary sarcoidosis. Intern Med 2005; 44:1276-1279.","DOI":"10.2169\/internalmedicine.44.1276"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Paramothayan NS, Lasserson TJ, and Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev 18:CD001114, 2005.","DOI":"10.1002\/14651858.CD001114.pub2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Arberts C, Van der Mark T W, and Jensen HM. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Eur Respir J 1995; 5:682-688.","DOI":"10.1183\/09031936.95.08050682"},{"key":"16","unstructured":"16. McGrath DS, Wells AU, Desai SR, Copley SJ, Kemp M et al. Efficacy, safety and tolerability of 3M HFA-134A beclomethasone dipropionate in pulmonary sarcoidosis. AJRCCM 2002; 165:A495."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Pietinalho A, Tukiainen P, Haahtela T, Persson T, Selroos O, and the Finnish Pulmonary Sarcoidosis Study Group. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis. A double-blind, placebo-controlled multicenter study. Chest 1999; 116:424-431.","DOI":"10.1378\/chest.116.2.424"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Spiteri MA, Newman SP, Clarke SW and Poulter LW. Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis. Eur Respir J 1989; 2:218-224.","DOI":"10.1183\/09031936.93.02030218"},{"key":"19","unstructured":"19. Ladwig-Sengpiel A, Jaksztat E, Welker L, Zeschnigk T, Kanniess F et al. Effect of beclomethasone dipropionate (BDP) as extrafine aerosol on bronchoalveolar lavage (BAL) lymphocytes in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:214-211."}],"container-title":["The Kurume Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/66\/1\/66_MS661003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T14:17:22Z","timestamp":1696083442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/66\/1\/66_MS661003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,31]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2739\/kurumemedj.ms661003","relation":{},"ISSN":["0023-5679","1881-2090"],"issn-type":[{"value":"0023-5679","type":"print"},{"value":"1881-2090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,31]]}}}